In this episode of Talking Trusts, we speak to William Heathcoat Amory, one of our Kepler Trust Intelligence analysts, about investing in the biotech sector with International Biotechnology Trust (IBT).
00:00 Introduction and risk warnings
00:31 An overview of IBT
01:42 Why might a biotech trust be interesting to investors?
03:24 What is the background of the managers?
05:12 How has the trust performed?
05:55 What are the benefits to a closed-ended structure in this space?
07:35 What are the current opportunities in the biotech sector?
Visit the IBT website - https://www.www.schroders.com/ibt
Read our latest research on IBT - https://www.trustintelligence.co.uk/investor/articles/fund-research-investor-international-biotechnology-retail-sep-2023
Disclaimer
Disclosure – Non-Independent Marketing Communication
This is a non-independent marketing communication commissioned by International Biotechnology. The report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on the dealing ahead of the dissemination of investment research.
